216 related articles for article (PubMed ID: 17655703)
1. Analysis of 6q deletion in Waldenstrom macroglobulinemia.
Chang H; Qi X; Xu W; Reader JC; Ning Y
Eur J Haematol; 2007 Sep; 79(3):244-7. PubMed ID: 17655703
[TBL] [Abstract][Full Text] [Related]
2. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of 6q deletion in Waldenström's macroglobulinemia: a multicenter study.
Chang H; Qi C; Trieu Y; Jiang A; Young KH; Chesney A; Jani P; Wang C; Reece D; Chen C
Clin Lymphoma Myeloma; 2009 Mar; 9(1):36-8. PubMed ID: 19362968
[TBL] [Abstract][Full Text] [Related]
4. 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis.
Ocio EM; Schop RF; Gonzalez B; Van Wier SA; Hernandez-Rivas JM; Gutierrez NC; Garcia-Sanz R; Moro MJ; Aguilera C; Hernandez J; Xu R; Greipp PR; Dispenzieri A; Jalal SM; Lacy MQ; Gonzalez-Paz N; Gertz MA; San Miguel JF; Fonseca R
Br J Haematol; 2007 Jan; 136(1):80-6. PubMed ID: 17222197
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.
Bang SM; Seo JW; Park KU; Kim SJ; Kim K; Kim SH; Cho SR; Kim HC; Song J; Kim JS; Kim KH; Lee JH; Lee JJ; Shin MG; Suh C; Chi HS; Oh DY; Won JH; Kim HJ; Yoon SS; Lee DS;
Cancer Genet Cytogenet; 2010 Mar; 197(2):117-21. PubMed ID: 20193844
[TBL] [Abstract][Full Text] [Related]
6. 6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival.
García-Sanz R; Dogliotti I; Zaccaria GM; Ocio EM; Rubio A; Murillo I; Escalante F; Aguilera C; García-Mateo A; García de Coca A; Hernández R; Dávila J; Puig N; García-Álvarez M; Chillón MDC; Alcoceba M; Medina A; González de la Calle V; Sarasquete ME; González M; Gutiérrez NC; Jiménez C
Br J Haematol; 2021 Mar; 192(5):843-852. PubMed ID: 32780894
[TBL] [Abstract][Full Text] [Related]
7. Genetics and cytogenetics of Waldenstrom's macroglobulinemia.
Schop RF; Fonseca R
Semin Oncol; 2003 Apr; 30(2):142-5. PubMed ID: 12720124
[TBL] [Abstract][Full Text] [Related]
8. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
Schop RF; Kuehl WM; Van Wier SA; Ahmann GJ; Price-Troska T; Bailey RJ; Jalal SM; Qi Y; Kyle RA; Greipp PR; Fonseca R
Blood; 2002 Oct; 100(8):2996-3001. PubMed ID: 12351413
[TBL] [Abstract][Full Text] [Related]
9. Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma.
Cook JR; Aguilera NI; Reshmi S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
Cancer Genet Cytogenet; 2005 Oct; 162(1):85-8. PubMed ID: 16157207
[TBL] [Abstract][Full Text] [Related]
10. [Delineation of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization].
Zhang Y; Zhou J; Weng L; Gu W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):20-3. PubMed ID: 10653903
[TBL] [Abstract][Full Text] [Related]
11. Chromosome band 6q deletion pattern in malignant lymphomas.
Taborelli M; Tibiletti MG; Martin V; Pozzi B; Bertoni F; Capella C
Cancer Genet Cytogenet; 2006 Mar; 165(2):106-13. PubMed ID: 16527604
[TBL] [Abstract][Full Text] [Related]
12. [Chromosomal abnormalities and Waldenström macroglobulinemia].
Berger R; Nguyen-Khac F
Pathol Biol (Paris); 2008 Sep; 56(6):400-6. PubMed ID: 18456427
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Profile Signature of Aggressive Waldenström Macroglobulinemia with Chromosome 6q Deletion.
Sekiguchi N; Nomoto J; Nagata A; Kiyota M; Fukuda I; Yamada K; Takezako N; Kobayashi Y
Biomed Res Int; 2018; 2018():6728128. PubMed ID: 30402490
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
[TBL] [Abstract][Full Text] [Related]
15. Rarity of IgH translocations in Waldenström macroglobulinemia.
Ackroyd S; O'Connor SJ; Owen RG
Cancer Genet Cytogenet; 2005 Nov; 163(1):77-80. PubMed ID: 16271961
[TBL] [Abstract][Full Text] [Related]
16. 6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
Dalsass A; Mestichelli F; Ruggieri M; Gaspari P; Pezzoni V; Vagnoni D; Angelini M; Angelini S; Bigazzi C; Falcioni S; Troiani E; Alesiani F; Catarini M; Attolico I; Scortechini I; Discepoli G; Galieni P
Eur J Haematol; 2013 Jul; 91(1):10-9. PubMed ID: 23560441
[TBL] [Abstract][Full Text] [Related]
17. Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
Schop RF; Jalal SM; Van Wier SA; Ahmann GJ; Bailey RJ; Kyle RA; Greipp PR; Rajkumar SV; Gertz MA; Lust JA; Lacy MQ; Dispenzieri A; Witzig TE; Fonseca R
Cancer Genet Cytogenet; 2002 Jan; 132(1):55-60. PubMed ID: 11801310
[TBL] [Abstract][Full Text] [Related]
18. Waldenström macroglobulinemia with karyotypic aberrations involving both homologous 6q.
Wong KF; So CC
Cancer Genet Cytogenet; 2001 Jan; 124(2):137-9. PubMed ID: 11172905
[TBL] [Abstract][Full Text] [Related]
19. MYD88 L265P mutations are correlated with 6q deletion in Korean patients with Waldenström macroglobulinemia.
Kim JA; Im K; Park SN; Kwon J; Choi Q; Hwang SM; Sekiguchi N; Yoon SS; Lee DS; Kim SY
Biomed Res Int; 2014; 2014():363540. PubMed ID: 24895570
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
Baldini L; Goldaniga M; Guffanti A; Broglia C; Cortelazzo S; Rossi A; Morra E; Colombi M; Callea V; Pogliani E; Ilariucci F; Luminari S; Morel P; Merlini G; Gobbi P
J Clin Oncol; 2005 Jul; 23(21):4662-8. PubMed ID: 16034042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
